SBTX Penny Biopharma on ROUNDED BOTTOM REVERSAL - Daily Chart

NASDAQ:SBTX


with upcoming earnings
chart shows
s

• upport and resistance from pivots
  ascending higher highs and higher lows
  support /resistance from long-term volume profile
  early reversal after May 13th earnings
  uptrending EMA ribbon
  pull back within the uptrend 7/15-7/27
  rising relative volume since May 13th earnings
  

NASDAQ:SBTX

The potential red flag is the company seems to be
setting up for a merger at the end of the year
and a press release suggests that the only product
will be a decongestant nose spray ( Niffy)
with a new ticker SPRY

So the question is trade off the curent techicals
but pay heed to fundamentals and upcoming guidance
from earnings ? What is your opinion ?